Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Typha latifolia pollen, widely known as Puhuang in Traditional Chinese Medicine, is a natural substance harvested from the male flowers of the common cattail. It is primarily utilized for its potent hemostatic properties, effective in treating both internal and external bleeding. The pollen's biological resilience is attributed to the presence of Late Embryogenesis Abundant (LEA) proteins and the formation of intracellular sugar glasses, which protect cellular integrity during desiccation. Pharmacological studies indicate that its active constituents, including flavonoids like quercetin and various sterols, contribute to its ability to promote blood circulation, resolve blood stasis, and exert anti-inflammatory effects.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on typha latifolia pollen.